---
title: "Top Eminent Healthcare to Acquire Online Healthcare Platform in HK$100.3 Million Connected Deal"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/277135842.md"
description: "Top Eminent Healthcare Group Limited will acquire 100% of Top Eminent II Limited for HK$100.3 million, a connected transaction under Hong Kong listing rules. The acquisition allows Top Eminent to consolidate financial results from PRC entities in internet-based healthcare. As the vendor is a subsidiary of the controlling shareholder, independent shareholder approval is required. An Independent Board Committee has been formed, and Ignite Capital (Asia Pacific) Limited will serve as the independent financial adviser. The latest analyst rating for CLSA Premium Ltd. (HK:6877) is a Hold with a price target of HK$0.15."
datetime: "2026-02-27T01:16:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/277135842.md)
  - [en](https://longbridge.com/en/news/277135842.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/277135842.md)
---

# Top Eminent Healthcare to Acquire Online Healthcare Platform in HK$100.3 Million Connected Deal

### Claim 50% Off TipRanks Premium

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

CLSA Premium Ltd. ( (HK:6877) ) has provided an update.

Top Eminent Healthcare Group Limited has agreed to acquire 100% of Top Eminent II Limited for HK$100.3 million, in a deal classified as both a major and connected transaction under Hong Kong listing rules. The target group controls PRC entities engaged in internet-based healthcare and online medical services via structured contracts, enabling Top Eminent Healthcare to consolidate their financial results and fully capture their economic benefits.

Because the vendor is a wholly owned subsidiary of the company’s controlling shareholder, the transaction is treated as a connected deal that requires independent shareholder approval and compliance with reporting, review and circular requirements. An Independent Board Committee has been formed and Ignite Capital (Asia Pacific) Limited appointed as independent financial adviser, with a circular detailing the acquisition and contractual arrangements to be sent to shareholders ahead of an extraordinary general meeting.

The most recent analyst rating on (HK:6877) stock is a Hold with a HK$0.15 price target. To see the full list of analyst forecasts on CLSA Premium Ltd. stock, see the HK:6877 Stock Forecast page.

**More about CLSA Premium Ltd.**

Top Eminent Healthcare Group Limited is a Cayman Islands-incorporated company listed in Hong Kong that operates in the healthcare sector. Through its subsidiaries and contractual arrangements in mainland China, the group focuses on internet-based healthcare, internet hospital services, online medical consultation and related value-added health management services aimed at the PRC market, where foreign ownership is restricted in this segment.

**Average Trading Volume:** 491,078

**Technical Sentiment Signal:** Sell

**Current Market Cap:** HK$300.9M

Learn more about 6877 stock on TipRanks’ Stock Analysis page.

### Related Stocks

- [513120.CN](https://longbridge.com/en/quote/513120.CN.md)
- [06877.HK](https://longbridge.com/en/quote/06877.HK.md)

## Related News & Research

- [20:03 ETHarbour BioMed Announces Promising Preclinical Data for LET003, Its First AI-Enabled Drug Candidate](https://longbridge.com/en/news/286688082.md)
- [Trade Futures Online: Regulated Access to Global Markets](https://longbridge.com/en/news/286775350.md)
- [Australian judge fines X $465,000 for online safety breach after 3-year court battle](https://longbridge.com/en/news/287160164.md)
- [Shanghai Xizhi switches non-registered investors to online disclosures by default](https://longbridge.com/en/news/287205161.md)
- [Alabama launches online surplus auction with wide-ranging items](https://longbridge.com/en/news/286655046.md)